HIV Market Forecast

In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiation, decreasing mortality and an increase in HIV prevalence, a series of patent expiries will impact branded sales from 2011.

Reasons to Purchase

• Understand the changing market dynamics of HIV drugs, success factors for leading brands and the commercial potential of late stage pipeline products
• Assess the impact of events such as patent expiries and new product launches on individual brands and the overall antiretroviral market.
• Obtain full global, country, class and product-specific forecasts of currently marketed and pipeline antiretrovirals from 2008 to 2018.